Neuroone Medical Technologies Corp (NMTC) - Net Assets

Latest as of March 2026: $5.37 Million USD

Based on the latest financial reports, Neuroone Medical Technologies Corp (NMTC) has net assets worth $5.37 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($7.86 Million) and total liabilities ($2.49 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Neuroone Medical Technologies Corp tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	$5.37 Million
% of Total Assets	68.32%
Annual Growth Rate	N/A
5-Year Change	7.91%
10-Year Change	N/A
Growth Volatility	307.72

Neuroone Medical Technologies Corp - Net Assets Trend (2010–2025)

This chart illustrates how Neuroone Medical Technologies Corp's net assets have evolved over time, based on quarterly financial data. See Neuroone Medical Technologies Corp (NMTC) defensive interval to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Neuroone Medical Technologies Corp (2010–2025)

The table below shows the annual net assets of Neuroone Medical Technologies Corp from 2010 to 2025. For live valuation and market cap data, see NMTC market cap overview.

Year	Net Assets	Change
2025-09-30	$7.07 Million	+760.39%
2024-09-30	$822.01K	-86.85%
2023-09-30	$6.25 Million	-34.93%
2022-09-30	$9.60 Million	+46.54%
2021-09-30	$6.55 Million	+217.20%
2020-09-30	$2.07 Million	+266.95%
2019-09-30	$-1.24 Million	+71.85%
2018-09-30	$-4.40 Million	-1551.23%
2017-09-30	$-266.22K	-226.68%
2016-09-30	$-81.49K	-130.27%
2015-09-30	$-35.39K	-25.06%
2014-09-30	$-28.30K	-64.17%
2013-09-30	$-17.24K	0.00%
2012-09-30	$-17.24K	-426.00%
2011-09-30	$-3.28K	+24.20%
2010-09-30	$-4.32K	--

Equity Component Analysis

This analysis shows how different components contribute to Neuroone Medical Technologies Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 7860096400.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (September 2025)

Component	Amount	Percentage
Common Stock	$50.01K	0.71%
Other Components	$85.63 Million	1210.77%
Total Equity	$7.07 Million	100.00%

Neuroone Medical Technologies Corp Competitors by Market Cap

The table below lists competitors of Neuroone Medical Technologies Corp ranked by their market capitalization.

Company	Market Cap
Eduspec Holdings Bhd KLSE:0107	$28.51 Million
Sufrin Holdings Ltd TA:SFRN	$28.51 Million
Barinthus Biotherapeutics plc NASDAQ:BRNS	$28.52 Million
Slj Global Tbk JK:SULI	$28.52 Million
Chariot Oil & Gas Limited F:C62	$28.48 Million
Inhome Prime Properties SOCIMI S.A. MC:YIPP	$28.48 Million
Ntaw Holdings Ltd AU:NTD	$28.48 Million
Veto Switchgears And Cables Limited NSE:VETO	$28.48 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Neuroone Medical Technologies Corp's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 822,013 to 7,072,522, a change of 6,250,509 (760.4%).
Net loss of 3,605,374 reduced equity.
Share repurchases of 124,617 reduced equity.
New share issuances of 9,614,037 increased equity.
Other factors increased equity by 366,463.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	$-3.61 Million	-50.98%
Share Repurchases	$124.62K	-1.76%
Share Issuances	$9.61 Million	+135.94%
Other Changes	$366.46K	+5.18%
Total Change	$-	760.39%

Book Value vs Market Value Analysis

This analysis compares Neuroone Medical Technologies Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 3.13x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2010-09-30	$-0.02	$3.31	x
2011-09-30	$-0.01	$3.31	x
2012-09-30	$0.00	$3.31	x
2013-09-30	$-0.06	$3.31	x
2014-09-30	$-0.10	$3.31	x
2015-09-30	$-0.13	$3.31	x
2016-09-30	$-0.05	$3.31	x
2017-09-30	$-0.94	$3.31	x
2018-09-30	$-9.40	$3.31	x
2019-09-30	$-1.88	$3.31	x
2020-09-30	$2.29	$3.31	x
2021-09-30	$3.68	$3.31	x
2022-09-30	$3.60	$3.31	x
2023-09-30	$2.07	$3.31	x
2024-09-30	$0.18	$3.31	x
2025-09-30	$1.06	$3.31	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Neuroone Medical Technologies Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -50.98%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -29.80%
• Asset Turnover: 1.12x
• Equity Multiplier: 1.53x
Recent ROE (-50.98%) is above the historical average (-165.96%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2010	0.00%	-517.91%	0.13x	0.00x	$-5.61K
2011	0.00%	-511.37%	0.39x	0.00x	$-27.28K
2012	0.00%	-1515.74%	0.82x	0.00x	$-12.24K
2013	0.00%	-1515.74%	0.82x	0.00x	$-12.24K
2014	0.00%	-2446.28%	2.05x	0.00x	$-27.72K
2015	0.00%	-4688.75%	3.77x	0.00x	$-32.71K
2016	0.00%	-8472.10%	0.40x	0.00x	$-54.71K
2017	0.00%	0.00%	0.00x	0.00x	$-21.15K
2018	0.00%	0.00%	0.00x	0.00x	$-6.39 Million
2019	0.00%	0.00%	0.00x	0.00x	$-6.66 Million
2020	-660.17%	-708.00%	0.40x	2.30x	$-13.85 Million
2021	-151.79%	-5584.28%	0.02x	1.21x	$-10.60 Million
2022	-104.12%	-5841.95%	0.01x	1.34x	$-10.96 Million
2023	-189.77%	-607.42%	0.24x	1.30x	$-12.48 Million
2024	-1498.53%	-356.74%	0.64x	6.53x	$-12.40 Million
2025	-50.98%	-29.80%	1.12x	1.53x	$-4.31 Million

Industry Comparison

This section compares Neuroone Medical Technologies Corp's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $1,818,520,110
Average return on equity (ROE) among peers: -48.87%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Neuroone Medical Technologies Corp (NMTC)	$5.37 Million	0.00%	0.46x	$28.49 Million
Abbott Laboratories (ABT)	$17.78 Billion	20.28%	1.23x	$153.89 Billion
Adagio Medical Holdings, Inc Common Stock (ADGM)	$19.91 Million	-270.00%	1.43x	$15.55 Million
Aethlon Medical Inc (AEMD)	$-5.98 Million	0.00%	0.00x	$2.51 Million
Acutus Medical Inc (AFIB)	$126.58 Million	-80.56%	0.52x	$903.35K
Adapthealth Corp (AHCO)	$280.85 Million	-57.55%	5.46x	$1.29 Billion
20/20 Biolabs, Inc. Common Stock (AIDX)	$6.89 Million	30.07%	0.49x	$6.67 Million
Allurion Technologies, Inc. (ALUR)	$-70.49 Million	0.00%	0.00x	$7.70 Million
Autonomix Medical, Inc. Common Stock (AMIX)	$8.10 Million	-140.88%	0.21x	$4.44 Million
Artivion Inc (AORT)	$17.90 Million	7.26%	0.20x	$1.03 Billion
Apyx Medical Inc (APYX)	$22.89 Million	2.69%	0.23x	$176.29 Million

About Neuroone Medical Technologies Corp

NASDAQ:NMTC USA Medical Devices

Market Cap

$28.49 Million

Market Cap Rank

#23996 Global

#5113 in USA

Share Price

$3.31

Change (1 day)

+1.69%

52-Week Range

$0.59 - $5.11

All Time High

$26.97